Overview
Status
Active
Registry date
2001-12-14
Share capital
50,000.00 PLN
Registered address
Sienkiewicza 12, 48-385 Otmuchów, Poland
Electronic delivery address
AE:PL-52877-22210-RAUAH-27
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 35 days early. 1 of 6 audited by a statutory auditor.
- 202511/06/2026
- 202428/03/2025
- 202328/06/2024
- 202229/06/2023
- 202129/06/2022
- 202029/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.05mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 27.74kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 1.97mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.35mMedianUSD 544.32kAverageUSD 1.76m
Industry
National Health Fund (NFZ) contracts
Apotex has been an NFZ healthcare provider since 2023. In 2026 it is performing 2 contracts with a total value of USD 21.90k. All its contracts were worth USD 37.49k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | opolskie | 2 | USD 21.90k |
Authorized Representatives
Marzenna Orłowska Plizga
Piotr Plizga – Attorney-in-fact (sole)
Manner of representation
President of the Management Board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jan Kazimierz Czabanowskiage 79 | 36 | $4,862.24 | 36% |
Marzenna Maria Orłowska Plizgaage 59 | 64 | $8,643.98 | 64% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2002-01-07.
37 1050 1490 1000 0022 6285 0031
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $65,129.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1$1 | Tauron Sprzedaż sp. z o.o. | |
| Dec 16, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,391$1,391 | Tauron Sprzedaż sp. z o.o. | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,899$1,899 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MybestpharmS.A. | $10,884,130.91 | mybestpharm.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Herbarium Świętego Franciszkasp. z o.o. | $1,397,577.12 | herbarium.katowice.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com |
Change history
| Date | Event | |
|---|---|---|
| 2006-02-10 | Share capital increase (25,000.00 PLN → 50,000.00 PLN) | |
| 2004-09-17 | Address change (Zjednoczenia 8/1, 48-300, Nysa → Sienkiewicza 12, 48-385, Otmuchów) | |
| 2001-12-14 | Entered in the register |
FAQ
The main business activity of Apotex focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on December 14, 2001.
The headquarters is located at: Sienkiewicza 12, 48-385 Otmuchów.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $2,047,258 in 2025, which is an increase of 16.3% compared to 2024.
Yes, the company recorded a net profit of $27,735 in 2025.
The largest operating cost category falls under other operating costs. This category amounted to $1,617,710 in 2025, representing 82% of all operating expenses.
Last updated: 2026-08-20